To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene INTS10TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
517 supporting clones for gene INTS10 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AW160632 brain, frontal lobe .a 1 to 356 1 to 356   tiling clone,   356/356
(100 %)
0 diff
(100 %id)
AW162502 brain, frontal lobe .a 1694 to 2154 474 to 15   tiling clone,   467/474
(98 %)
1 diff
(99.8 %id)
EB385690 eye, optic nerve .a 1785 to 2557 1 to 773   tiling clone, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 773/773
(100 %)
3 diff
(99.7 %id)
AA195647 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1890 to 2179 1 to 290   fully sequenced,   290/290
(100 %)
1 diff
(99.7 %id)
AW162504.
matches multiple genes
brain, frontal lobe .a 1990 to 2154 170 to 6     also hits gene HMGN3 170/170
(100 %)
0 diff
(100 %id)
DB575546 hypothalamus .a 2069 to 2567 1 to 499     Submitted on the opposite strand 499/501
(99 %)
5 diff
(99.1 %id)
DB568145 hypothalamus .a 2086 to 2567 1 to 481     Submitted on the opposite strand 481/483
(99 %)
4 diff
(99.2 %id)
DB541876 hippocampus .a 2094 to 2563 1 to 470   tiling clone, Submitted on the opposite strand 470/472
(99 %)
2 diff
(99.6 %id)
DB539763 hippocampus .a 2103 to 2556 1 to 455     Submitted on the opposite strand 455/456
(99 %)
4 diff
(99.2 %id)
DB548598 hippocampus .a 2107 to 2563 1 to 457     Submitted on the opposite strand 457/459
(99 %)
2 diff
(99.6 %id)
DB535459 hippocampus .a 2115 to 2556 1 to 442     Submitted on the opposite strand 442/443
(99 %)
1 diff
(99.8 %id)
AA195648 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 2118 to 2567 460 to 12   fully sequenced,   449/460
(97 %)
0 diff
(100 %id)
DB531658 hippocampus .a 2123 to 2556 1 to 434     Submitted on the opposite strand 434/435
(99 %)
1 diff
(99.8 %id)
DA420892 cervix .b 1 to 566 2 to 568   tiling clone, capped   567/567
(100 %)
1 diff
(99.9 %id)
DA819655   .b 8 to 563 2 to 563   capped   562/562
(100 %)
4 diff
(99.3 %id)
DA235226 brain .b 10 to 593 2 to 586   capped   585/585
(100 %)
3 diff
(99.5 %id)
DA466433   .b 10 to 574 2 to 567   tiling clone, capped   566/566
(100 %)
2 diff
(99.7 %id)
AA160416 Pancreas .b 29 to 341 1 to 305     Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 305/305
(100 %)
17 diff
(94.5 %id)
BG722468 testis .b 166 to 980 1 to 811       814/813
(100 %)
16 diff
(98.1 %id)
DB134524 thymus .b 226 to 777 2 to 560   capped   559/559
(100 %)
4 diff
(99.3 %id)
DA296771 hippocampus .b 233 to 812 2 to 582   capped   581/581
(100 %)
2 diff
(99.7 %id)
DA871765 Prostate .b 252 to 796 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DB271507 uterus .b 252 to 795 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
DA955767 Spleen .b 253 to 824 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA344565 substantia nigra .b 263 to 806 2 to 546   capped   545/545
(100 %)
1 diff
(99.9 %id)
BM547763 brain, hippocampus .b 267 to 1167 1 to 909       909/1107
(82 %)
17 diff
(98.5 %id)
NM_018142.2   .b 267 to 2805 1 to 2539   RefSeq,   2539/2539
(100 %)
2 diff
(100.0 %id)
DA577052   .b 277 to 831 2 to 556   capped   555/555
(100 %)
2 diff
(99.7 %id)
CD674783 eye, lens .b 279 to 913 1 to 635       635/635
(100 %)
0 diff
(100 %id)
BP273151   .b 280 to 859 1 to 580       580/580
(100 %)
19 diff
(96.8 %id)
BM757469 stomach .b 280 to 790 1 to 510       510/510
(100 %)
1 diff
(99.9 %id)
BP334639 salivary gland .b 280 to 863 1 to 584       584/584
(100 %)
0 diff
(100 %id)
DA165657 amygdala .b 281 to 852 2 to 579   capped   578/578
(100 %)
2 diff
(99.7 %id)
DA329595 hippocampus .b 281 to 806 2 to 526   capped   525/525
(100 %)
2 diff
(99.7 %id)
DA400589 thalamus .b 281 to 820 2 to 547   capped   546/546
(100 %)
3 diff
(99.5 %id)
DA497296 brain .b 281 to 869 2 to 590   capped   589/589
(100 %)
0 diff
(100 %id)
DA584359 lung .b 281 to 814 2 to 536   capped   535/535
(100 %)
2 diff
(99.7 %id)
BG706223 brain, hypothalamus .b 281 to 1012 1 to 731       733/737
(99 %)
16 diff
(97.9 %id)
DA679343   .b 281 to 838 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA714584   .b 281 to 838 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
DA986537 synovial membrane tissue from rheumatioidarthritis .b 281 to 847 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA998307   .b 281 to 775 2 to 496   capped   495/495
(100 %)
1 diff
(99.8 %id)
DB015558 esophageal, tumor tissue .b 281 to 813 2 to 534   capped   533/533
(100 %)
0 diff
(100 %id)
DB196490 trachea .b 281 to 850 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
DB210425 trachea .b 281 to 831 2 to 550   capped   549/549
(100 %)
1 diff
(99.9 %id)
DB447914 testis .b 286 to 710 1 to 425       425/425
(100 %)
0 diff
(100 %id)
DB497115 hypothalamus .b 286 to 767 1 to 482       482/482
(100 %)
3 diff
(99.4 %id)
DB504303 hypothalamus .b 286 to 763 1 to 478       478/478
(100 %)
2 diff
(99.6 %id)
BP253938 Kidney .b 287 to 867 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
CR976103 T-Lymphocytes .b 287 to 1080 1 to 794       794/796
(99 %)
1 diff
(99.9 %id)
BM542591 leiomyosarcoma, uterus .b 288 to 926 91 to 734       644/1370
(47 %)
29 diff
(97.9 %id)
DA816777   .b 296 to 775 2 to 483   capped   482/482
(100 %)
6 diff
(98.8 %id)
CR986878 T-Lymphocytes .b 296 to 1078 1 to 787       787/787
(100 %)
5 diff
(99.4 %id)
CN426429 embryonic stem cells, DMSO-treated H9 cellline .b 297 to 522 1 to 226       226/226
(100 %)
0 diff
(100 %id)
BG622158 placenta .b 297 to 1119 1 to 819       819/820
(99 %)
25 diff
(97.0 %id)
BU172986 leiomyosarcoma, uterus .b 298 to 1070 6 to 787       782/877
(89 %)
25 diff
(97.2 %id)
BU509120 leiomyosarcoma, uterus .b 298 to 1061 1 to 774       774/925
(83 %)
19 diff
(98.0 %id)
CV572752 cornea, eye .b 299 to 935 1 to 637       637/637
(100 %)
2 diff
(99.7 %id)
DB451921 testis .b 301 to 802 1 to 502       502/502
(100 %)
1 diff
(99.9 %id)
DA464571   .b 305 to 868 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
BX956211   .b 307 to 759 1 to 453       453/453
(100 %)
1 diff
(99.8 %id)
DA272424 caudate nucleus .b 308 to 868 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
BG479798 choriocarcinoma, placenta .b 311 to 1114 1 to 814       810/874
(92 %)
21 diff
(97.6 %id)
BE615803 adenocarcinoma, Pancreas .b 317 to 1095 1 to 778       778/778
(100 %)
8 diff
(99.0 %id)
BE797136 lung, small cell carcinoma .b 317 to 1062 1 to 740       740/841
(87 %)
14 diff
(98.4 %id)
CR598741 Placenta Cot 25-normalized .b 319 to 2749 1 to 2431   tiling clone,   2431/2431
(100 %)
0 diff
(100 %id)
AL554301 placenta, Placenta Cot 25-normalized .b 319 to 1198 1 to 881       881/881
(100 %)
5 diff
(99.5 %id)
DB473118 hippocampus .b 319 to 793 1 to 475       475/476
(99 %)
3 diff
(99.4 %id)
DB479862 hippocampus .b 319 to 820 1 to 503       503/503
(100 %)
4 diff
(99.3 %id)
BE614843 adenocarcinoma, Pancreas .b 319 to 944 1 to 624       624/625
(99 %)
3 diff
(99.6 %id)
BX462691.
matches multiple genes
T cells (Jurkat cell line) .b 321 to 972 1 to 652     also hits gene SMNDC1 652/652
(100 %)
1 diff
(99.9 %id)
BM010075 amelanotic melanoma, cell line, skin .b 322 to 1148 1 to 839       839/840
(99 %)
31 diff
(96.4 %id)
TI_59384871   .b 322 to 1148 104 to 942       839/840
(99 %)
31 diff
(96.4 %id)
BU147168 dorsal root ganglia .b 323 to 1183 1 to 865       865/866
(99 %)
6 diff
(99.4 %id)
BI561180 testis .b 324 to 1120 1 to 793       793/793
(100 %)
22 diff
(97.3 %id)
BM469681 embryonal carcinoma, cell line, testis .b 324 to 1232 1 to 914       914/1024
(89 %)
22 diff
(97.9 %id)
BM905641 leiomyosarcoma, uterus .b 325 to 1353 1 to 1037       1037/1037
(100 %)
29 diff
(97.3 %id)
BI832061 brain, medulla .b 326 to 944 1 to 631       631/631
(100 %)
24 diff
(96.2 %id)
TI_57173065   .b 326 to 944 1 to 631       631/631
(100 %)
24 diff
(96.2 %id)
DN989345 brain, whole brain .b 326 to 920 7 to 602       596/603
(98 %)
4 diff
(99.4 %id)
TI_44348859   .b 329 to 1120 88 to 875       788/875
(90 %)
22 diff
(97.5 %id)
BE890402 melanotic melanoma, skin .b 336 to 1062 1 to 732       732/791
(92 %)
19 diff
(97.6 %id)
DA878791 Prostate .b 339 to 907 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
BE895671 melanotic melanoma, skin .b 340 to 920 1 to 586       586/1079
(54 %)
8 diff
(99.3 %id)
AK001431   .b 346 to 2798 1 to 2452 S91Y Q92R D93T K94N Q95K ... available from FLJ,   2452/2452
(100 %)
3 diff
(99.9 %id)
AU128267   .b 346 to 1062 2 to 721   capped   720/759
(94 %)
17 diff
(97.8 %id)
BG106686 lymph, lymphoma, cell line .b 353 to 1075 1 to 712       712/928
(76 %)
24 diff
(97.5 %id)
AW407686 lymph .b 359 to 796 8 to 445       438/445
(98 %)
7 diff
(98.5 %id)
TI_154146272   .b 359 to 1033 72 to 746       675/678
(99 %)
27 diff
(96.1 %id)
BM462809 melanotic melanoma, skin .b 369 to 1169 1 to 807       807/1025
(78 %)
15 diff
(98.6 %id)
DA868310 Prostate .b 445 to 1016 2 to 576   capped   575/575
(100 %)
3 diff
(99.5 %id)
BE888342 leiomyosarcoma, uterus .b 491 to 1239 1 to 736       736/888
(82 %)
20 diff
(97.8 %id)
DA298352 hippocampus .b 541 to 1115 2 to 577   capped   576/577
(99 %)
2 diff
(99.7 %id)
BM710680 eye, fetal eyes .b 543 to 1002 1 to 460     Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 460/460
(100 %)
1 diff
(99.8 %id)
BM838561 Ascites, stomach .b 552 to 1014 1 to 463       463/463
(100 %)
3 diff
(99.4 %id)
CB162960 Liver .b 556 to 1165 1 to 609       609/609
(100 %)
1 diff
(99.9 %id)
EH335518   .b 595 to 680 1 to 85       85/85
(100 %)
1 diff
(98.9 %id)
BG683047 brain, neuroblastoma, cell line .b 615 to 1462 1 to 849       849/850
(99 %)
11 diff
(98.8 %id)
BC051282 Brain, neuroblastoma .b 616 to 2788 1 to 2173   available from MGC, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 2173/2175
(99 %)
2 diff
(100.0 %id)
BU501649 brain, neuroblastoma, cell line .b 617 to 1232 1 to 617   available from MGC,   617/923
(66 %)
5 diff
(99.5 %id)
BC001915 Lung, small cell carcinoma .b 630 to 2790 1 to 2161   available from MGC, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 2161/2161
(100 %)
1 diff
(100.0 %id)
BC006209 Lung, small cell carcinoma .b 630 to 2790 1 to 2161   available from MGC, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 2161/2161
(100 %)
1 diff
(100.0 %id)
DW447846 Liver .b 640 to 825 22 to 211       190/211
(90 %)
14 diff
(93.4 %id)
CD677570 eye, Trabecular meshwork .b 648 to 1209 1 to 561       561/561
(100 %)
3 diff
(99.5 %id)
BP338447 Spleen .b 651 to 1233 1 to 583       583/583
(100 %)
0 diff
(100 %id)
DB260271 uterus .b 657 to 1215 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
BE206904 lung, small cell carcinoma .b 659 to 1009 1 to 351   available from MGC,   351/351
(100 %)
2 diff
(99.5 %id)
BM455206 lymph, lymphoma, cell line .b 664 to 1685 11 to 1044       1031/1090
(94 %)
34 diff
(96.9 %id)
CV800573 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 675 to 1353 1 to 675       675/823
(82 %)
5 diff
(99.4 %id)
CX164848 human embryonic stem cells differentiated toan early endodermal cell type .b 678 to 1328 11 to 662       652/662
(98 %)
7 diff
(99.0 %id)
DA706179   .b 696 to 1255 2 to 562   capped   561/561
(100 %)
4 diff
(99.3 %id)
BQ233274 embryonal carcinoma, cell line, testis .b 699 to 1537 1 to 840       840/846
(99 %)
2 diff
(99.8 %id)
DA430537 colon .b 706 to 1265 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
DA706291   .b 711 to 1267 2 to 559   capped   558/558
(100 %)
3 diff
(99.5 %id)
AV751049 Pituitary .b 726 to 1040 36 to 343       313/346
(90 %)
17 diff
(95.1 %id)
TI_1948147036   .b 733 to 1475 129 to 876       748/1320
(56 %)
36 diff
(97.3 %id)
TI_1948147037   .b 733 to 1538 123 to 934       812/1414
(57 %)
22 diff
(98.5 %id)
TI_1948147352   .b 733 to 1487 131 to 897       767/1262
(60 %)
26 diff
(98.0 %id)
TI_1948147353   .b 733 to 1441 127 to 833       707/1333
(53 %)
19 diff
(98.6 %id)
TI_1948147682   .b 733 to 1436 131 to 834       704/1295
(54 %)
20 diff
(98.5 %id)
TI_1948147683   .b 733 to 1463 127 to 859       732/1344
(54 %)
19 diff
(98.6 %id)
TI_1948148011   .b 733 to 1534 125 to 930       806/1279
(63 %)
38 diff
(97.1 %id)
TI_1948148012   .b 733 to 1464 126 to 857       732/1365
(53 %)
28 diff
(98.0 %id)
CR457262   .b 737 to 2526 1 to 1790       1790/1794
(99 %)
2 diff
(99.9 %id)
CV026038 mixed .b 737 to 1391 1 to 655       655/655
(100 %)
1 diff
(99.9 %id)
BF036110 adenocarcinoma, ovary .b 745 to 1485 1 to 733       733/820
(89 %)
16 diff
(98.1 %id)
DA046151 bladder .b 775 to 1353 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
BI334391 cervical carcinoma cell line, cervix .b 776 to 1455 1 to 679       679/679
(100 %)
1 diff
(99.9 %id)
BM014258 breast, mammary adenocarcinoma, cell line .b 779 to 1464 1 to 681       683/682
(100 %)
6 diff
(99.2 %id)
TI_59392251   .b 779 to 1464 100 to 780       683/682
(100 %)
6 diff
(99.2 %id)
BQ636691 eye, retina .b 836 to 1456 1 to 621       621/621
(100 %)
0 diff
(100 %id)
BX483017   .b 859 to 1464 1 to 608       608/612
(99 %)
3 diff
(99.6 %id)
AU136758 placenta .b 909 to 1664 2 to 763   capped   762/762
(100 %)
6 diff
(99.3 %id)
EC523227 Prostate .b 910 to 1018 2 to 110       109/110
(99 %)
6 diff
(94.6 %id)
EC468896 Prostate .b 914 to 1020 1 to 107       107/107
(100 %)
0 diff
(100 %id)
BU198715   .b 920 to 1538 14 to 637       624/790
(78 %)
37 diff
(95.4 %id)
EC551222 Prostate .b 922 to 1013 13 to 101       89/106
(83 %)
3 diff
(97.2 %id)
EC461648 Prostate .b 927 to 1029 1 to 101       101/102
(99 %)
5 diff
(95.1 %id)
AA307138 colon .b 938 to 1332 1 to 395       395/395
(100 %)
1 diff
(99.8 %id)
AA389754   .b 941 to 1187 1 to 247       247/247
(100 %)
14 diff
(94.4 %id)
BP264549 umbilical vein .b 942 to 1495 1 to 554       554/554
(100 %)
3 diff
(99.5 %id)
EC514664 Prostate .b 946 to 1048 1 to 100       100/100
(100 %)
4 diff
(96.0 %id)
CF141609 CNCAP(3)T-225 cell line, Prostate .b 948 to 1431 8 to 491       484/491
(98 %)
6 diff
(98.8 %id)
TI_154172385   .b 948 to 1528 81 to 661       581/581
(100 %)
6 diff
(99.0 %id)
DB128934 thymus .b 949 to 1490 2 to 544   capped   543/543
(100 %)
1 diff
(99.9 %id)
GD155987   .b 953 to 1050 1 to 98   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 98/99
(98 %)
8 diff
(92.0 %id)
CF141827 CNCAP(3)T-225 cell line, Prostate .b 974 to 1507 1 to 534       534/534
(100 %)
7 diff
(98.7 %id)
TI_154172655   .b 981 to 1578 80 to 681       599/603
(99 %)
9 diff
(98.6 %id)
BE747910 adenocarcinoma cell line, ovary .b 986 to 1775 39 to 826       788/833
(94 %)
14 diff
(98.4 %id)
BP227341   .b 1013 to 1591 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
BP336132 coronary artery .b 1014 to 1593 1 to 583       583/583
(100 %)
3 diff
(99.5 %id)
BP260378 heart .b 1043 to 1619 1 to 580       580/580
(100 %)
2 diff
(99.7 %id)
AA323696 brain, cerebellum .b 1047 to 1468 1 to 425       425/430
(98 %)
7 diff
(98.4 %id)
AW955166   .b 1048 to 1691 1 to 639       639/646
(98 %)
7 diff
(99.0 %id)
CR601199 Placenta Cot 25-normalized .b 1061 to 2762 1 to 1702       1702/1702
(100 %)
0 diff
(100 %id)
CR606025 neuroblastoma .b 1061 to 2625 1 to 1565       1565/1565
(100 %)
0 diff
(100 %id)
AL517933 brain, neuroblastoma, neuroblastoma cells .b 1061 to 1937 1 to 876   fully sequenced,   876/876
(100 %)
9 diff
(99.0 %id)
AL546937 placenta, Placenta Cot 25-normalized .b 1061 to 1958 1 to 894   fully sequenced,   894/894
(100 %)
3 diff
(99.7 %id)
AA702327 liver and spleen .b 1062 to 1517 456 to 1       456/456
(100 %)
0 diff
(100 %id)
AW796786 uterus .b 1069 to 1405 8 to 344       337/361
(93 %)
7 diff
(98.1 %id)
BU845885 ovary, teratocarcinoma, cell line .b 1081 to 1753 1 to 676       676/873
(77 %)
11 diff
(98.8 %id)
BU855959 ovary, teratocarcinoma, cell line .b 1081 to 1975 1 to 898       898/900
(99 %)
7 diff
(99.3 %id)
BX369372 Placenta Cot 25-normalized .b 1091 to 1537 1 to 445       445/449
(99 %)
20 diff
(95.6 %id)
BX369373 Placenta Cot 25-normalized .b 1092 to 1930 1 to 837       837/915
(91 %)
30 diff
(96.8 %id)
BI754624 brain .b 1121 to 2018 1 to 899       899/958
(93 %)
13 diff
(98.7 %id)
TI_57217256   .b 1121 to 2018 34 to 932       899/991
(90 %)
18 diff
(98.2 %id)
BX281308 brain .b 1123 to 1650 1 to 528       528/528
(100 %)
0 diff
(100 %id)
DA539482 Kidney .b 1140 to 1730 2 to 593   capped   592/592
(100 %)
1 diff
(99.9 %id)
BM017712 astrocytoma grade IV, cell line, brain .b 1140 to 1865 1 to 722       722/723
(99 %)
10 diff
(98.7 %id)
BM020991 astrocytoma grade IV, cell line, brain .b 1140 to 1880 1 to 737       737/737
(100 %)
7 diff
(99.1 %id)
BM018448 astrocytoma grade IV, cell line, brain .b 1140 to 1648 1 to 509       509/509
(100 %)
8 diff
(98.5 %id)
TI_59388283   .b 1141 to 1865 104 to 824       721/722
(99 %)
9 diff
(98.8 %id)
TI_59389037   .b 1141 to 1648 116 to 623       508/508
(100 %)
7 diff
(98.7 %id)
TI_59389109   .b 1141 to 1880 107 to 842       736/736
(100 %)
6 diff
(99.2 %id)
BG327327 Kidney, renal cell adenocarcinoma .b 1173 to 1826 1 to 655       655/656
(99 %)
4 diff
(99.4 %id)
BI086877 cervix .b 1173 to 1983 1 to 809       809/809
(100 %)
8 diff
(99.1 %id)
CF141077 CNCAP(3)T-225 cell line, Prostate .b 1193 to 1533 8 to 348       341/348
(97 %)
7 diff
(98.0 %id)
BU597331 mixed (pool of 40 RNAs) .b 1218 to 2035 1 to 820       820/832
(98 %)
11 diff
(98.7 %id)
FN069106 breast carcinoma .b 1233 to 1316 88 to 1     Submitted on the opposite strand 88/91
(96 %)
5 diff
(94.6 %id)
CF126067 Chondrosarcoma Lung Metastasis cell lines, lung .b 1247 to 1987 1 to 741       741/741
(100 %)
0 diff
(100 %id)
TI_154188899   .b 1247 to 2034 52 to 835   AAA   784/936
(83 %)
9 diff
(99.1 %id)
BQ644819 hepatocellular carcinoma, cell line, Liver .b 1255 to 1861 1 to 608       608/1060
(57 %)
12 diff
(98.9 %id)
BG748311 eye, normal pigmented retinal epithelium .b 1259 to 1937 1 to 682       682/712
(95 %)
16 diff
(97.8 %id)
W27152 eye, retina .b 1288 to 1682 10 to 404       395/426
(92 %)
3 diff
(99.3 %id)
CF139217 CNCAP(3)T-225 cell line, Prostate .b 1293 to 1823 1 to 531       531/531
(100 %)
6 diff
(98.9 %id)
CF121372 CNCAP(3)T-225 cell line, Prostate .b 1293 to 1980 1 to 687       687/687
(100 %)
8 diff
(98.9 %id)
TI_154169461   .b 1300 to 2037 91 to 831       741/908
(81 %)
23 diff
(97.5 %id)
TI_154180413   .b 1300 to 2265 78 to 1036       959/964
(99 %)
18 diff
(98.2 %id)
BM689316 eye, optic nerve .b 1317 to 1783 9 to 475     Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 467/475
(98 %)
0 diff
(100 %id)
CB999953 Pooled-Skin .b 1319 to 2018 1 to 701       701/701
(100 %)
5 diff
(99.3 %id)
FN050684 breast carcinoma .b 1328 to 1424 1 to 97       97/97
(100 %)
0 diff
(100 %id)
BM728105 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 1336 to 1970 1 to 635     Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 635/635
(100 %)
0 diff
(100 %id)
AL528754 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .b 1359 to 1863 1 to 504       504/504
(100 %)
5 diff
(99.1 %id)
BF082337 breast_normal .b 1381 to 1774 413 to 15       398/413
(96 %)
9 diff
(97.9 %id)
BQ953395 epidermoid carcinoma, cell line, lung .b 1402 to 2276 8 to 897       890/964
(92 %)
23 diff
(97.7 %id)
R14450 whole brain .b 1408 to 1729 1 to 322     Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 322/322
(100 %)
4 diff
(98.8 %id)
BI027366 marrow .b 1421 to 1732 9 to 316       308/323
(95 %)
8 diff
(97.6 %id)
BI762572 pooled colon, kidney, stomach .b 1424 to 2165 1 to 742       742/743
(99 %)
2 diff
(99.8 %id)
TI_57150470   .b 1424 to 2165 31 to 772       742/773
(95 %)
7 diff
(99.1 %id)
BG403130 bladder, transitional cell papilloma, cell line .b 1439 to 2066 1 to 625       625/625
(100 %)
3 diff
(99.6 %id)
BE933089 head_neck .b 1440 to 1609 1 to 171       171/171
(100 %)
6 diff
(96.5 %id)
BQ673848 epidermoid carcinoma, cell line, salivary gland .b 1451 to 2279 1 to 835       835/941
(88 %)
7 diff
(99.3 %id)
CD673019 eye, Iris .b 1484 to 2165 1 to 682       682/682
(100 %)
0 diff
(100 %id)
BQ898147 brain, neuroblastoma, cell line .b 1500 to 2407 23 to 932       910/937
(97 %)
10 diff
(99.0 %id)
BM817537 Ascites, stomach .b 1520 to 1812 1 to 293       293/293
(100 %)
0 diff
(100 %id)
AL442078 lymph node .b 1526 to 2788 1 to 1263   available from DKFZ, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 1263/1265
(99 %)
1 diff
(100.0 %id)
AA136257 lung, lung carcinoma .b 1527 to 1821 1 to 296   fully sequenced,   296/296
(100 %)
6 diff
(98.0 %id)
BE386181 melanotic melanoma, skin .b 1541 to 2205 1 to 665       665/665
(100 %)
3 diff
(99.6 %id)
BE727318 melanotic melanoma, skin .b 1541 to 2051 1 to 511       511/513
(99 %)
1 diff
(99.9 %id)
BP289750 lung .b 1546 to 2121 1 to 576       576/580
(99 %)
3 diff
(99.5 %id)
TI_1948147354   .b 1550 to 2529 1102 to 128       975/1493
(65 %)
23 diff
(98.5 %id)
BM739794 Ascites, stomach .b 1556 to 2150 1 to 592       592/592
(100 %)
8 diff
(98.7 %id)
AV755758 bone marrow .b 1561 to 2208 89 to 729       641/733
(87 %)
11 diff
(98.5 %id)
TI_57193623   .b 1562 to 2259 47 to 743       697/697
(100 %)
2 diff
(99.8 %id)
BI858474 breast, mammary adenocarcinoma, cell line .b 1563 to 2259 1 to 696       696/696
(100 %)
2 diff
(99.8 %id)
TI_1948147685   .b 1591 to 2529 1064 to 125       940/1422
(66 %)
15 diff
(99.0 %id)
CB216206 normal endometrium, mid-secretory phase,cycle day 23, uterus .b 1612 to 2212 1 to 601       601/601
(100 %)
0 diff
(100 %id)
BU072094 Pancreas, Purified pancreatic islet .b 1613 to 2303 6 to 696       691/696
(99 %)
7 diff
(99.0 %id)
TI_1948147038   .b 1619 to 2529 1025 to 122       904/1412
(64 %)
23 diff
(98.4 %id)
BF951217 nervous_normal .b 1654 to 1870 84 to 301       218/302
(72 %)
7 diff
(97.7 %id)
CK902476 Pancreas, Purified pancreatic islet .b 1656 to 2195 1 to 540     Submitted on the opposite strand 540/540
(100 %)
2 diff
(99.7 %id)
BE787850 large cell carcinoma, lung .b 1657 to 2374 1 to 713       711/762
(93 %)
21 diff
(97.3 %id)
BI253426 cervical carcinoma cell line, cervix .b 1687 to 2542 1 to 871       871/882
(98 %)
31 diff
(96.5 %id)
BQ302753 breast .b 1697 to 2153 478 to 21       458/478
(95 %)
1 diff
(99.8 %id)
BP293770 lung .b 1700 to 2273 1 to 574       574/574
(100 %)
4 diff
(99.4 %id)
BQ436839 embryonal carcinoma, cell line, testis .b 1703 to 2283 16 to 597       582/992
(58 %)
12 diff
(98.8 %id)
BF171789 blood .b 1705 to 1992 35 to 324       290/324
(89 %)
36 diff
(88.9 %id)
BE741956 adenocarcinoma cell line, ovary .b 1739 to 2243 1 to 511       511/934
(54 %)
13 diff
(98.7 %id)
BE315446 adenocarcinoma cell line, ovary .b 1760 to 2241 1 to 482   AAA   482/482
(100 %)
1 diff
(99.8 %id)
BE514684 adenocarcinoma cell line, ovary .b 1760 to 2241 1 to 482   AAA   482/482
(100 %)
0 diff
(100 %id)
BE744125 adenocarcinoma cell line, ovary .b 1760 to 2241 1 to 481   AAA   481/481
(100 %)
1 diff
(99.8 %id)
BM543344 embryonal carcinoma, cell line, testis .b 1773 to 2787 1049 to 34     Submitted on the opposite strand 1016/1076
(94 %)
11 diff
(99.0 %id)
BE539603 cervix .b 1784 to 2489 1 to 714       714/774
(92 %)
27 diff
(96.6 %id)
AA328810   .b 1797 to 2241 1 to 444       444/444
(100 %)
1 diff
(99.8 %id)
AW952465   .b 1798 to 2340 1 to 543       543/543
(100 %)
0 diff
(100 %id)
AA135941 lung, lung carcinoma .b 1820 to 2240 423 to 2   fully sequenced,   422/423
(99 %)
1 diff
(99.8 %id)
BM854480 Ascites, stomach .b 1839 to 2292 1 to 454       454/454
(100 %)
0 diff
(100 %id)
EC563007 Prostate .b 1844 to 1927 1 to 82       82/83
(98 %)
3 diff
(96.4 %id)
AL577047 placenta, Placenta Cot 25-normalized .b 1846 to 2743 904 to 7       898/904
(99 %)
5 diff
(99.5 %id)
CN426428 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 1847 to 2256 1 to 410       410/410
(100 %)
4 diff
(99.1 %id)
AI085028 liver and spleen .b 1856 to 2241 386 to 1       386/386
(100 %)
0 diff
(100 %id)
CB963700 Blood vessels - aorta, basilar and artery .b 1872 to 2567 1 to 705       705/775
(90 %)
15 diff
(98.1 %id)
AL517932 brain, neuroblastoma, neuroblastoma cells .b 1897 to 2625 726 to 1   fully sequenced,   726/726
(100 %)
11 diff
(98.5 %id)
AL572086 placenta, Placenta Cot 25-normalized .b 1897 to 2762 862 to 1   fully sequenced,   862/862
(100 %)
1 diff
(99.9 %id)
TI_1948147684   .b 1933 to 2529 739 to 139       601/1390
(43 %)
11 diff
(99.3 %id)
TI_149301547   .b 1952 to 2782 916 to 94   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 823/937
(87 %)
26 diff
(97.3 %id)
TI_159694659   .b 1952 to 2788 923 to 97       829/1065
(77 %)
18 diff
(98.4 %id)
BG683702 brain, neuroblastoma, cell line .b 1974 to 2387 418 to 1       418/418
(100 %)
4 diff
(99.1 %id)
BM824725 Ascites, stomach .b 1978 to 2479 1 to 502       502/502
(100 %)
0 diff
(100 %id)
TI_154192281   .b 2020 to 2792 50 to 820       771/973
(79 %)
8 diff
(99.2 %id)
CF130324 Chondrosarcoma Lung Metastasis cell lines, lung .b 2021 to 2729 1 to 707       707/707
(100 %)
2 diff
(99.8 %id)
AA148219   .b 2039 to 2485 452 to 2       449/475
(94 %)
8 diff
(98.4 %id)
BU633470 cell lines, Chondrosarcoma .b 2047 to 2792 762 to 17       746/762
(97 %)
1 diff
(99.9 %id)
BQ001733 lung, Metastatic Chondrosarcoma .b 2075 to 2792 734 to 17       718/734
(97 %)
0 diff
(100 %id)
CA308043 Alveolar Macrophage, lung .b 2090 to 2790 718 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 700/700
(100 %)
1 diff
(99.9 %id)
BQ182457 Knee, Osteoarthritic Cartilage .b 2128 to 2782 673 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 655/655
(100 %)
2 diff
(99.7 %id)
BG116190 duodenal adenocarcinoma, cell line, small intestine .b 2131 to 2802 1 to 672       672/683
(98 %)
10 diff
(98.6 %id)
BU953722 mixed (pool of 40 RNAs) .b 2147 to 2786 1 to 646       646/716
(90 %)
14 diff
(98.1 %id)
TI_154010677   .b 2148 to 2782 757 to 125   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 633/1089
(58 %)
13 diff
(98.9 %id)
AL546485 placenta, Placenta Cot 25-normalized .b 2149 to 2792 1 to 644       644/644
(100 %)
2 diff
(99.7 %id)
BQ276952 mixed (pool of 40 RNAs) .b 2153 to 2788 1 to 638       638/918
(69 %)
6 diff
(99.4 %id)
BM979976 lung, Primary Lung Cystic Fibrosis EpithelialCells .b 2154 to 2782 647 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 629/629
(100 %)
0 diff
(100 %id)
BU076082 Pancreas, Purified pancreatic islet .b 2187 to 2782 597 to 3       595/597
(99 %)
0 diff
(100 %id)
AA553813 colon, tumor .b 2190 to 2486 297 to 1       297/297
(100 %)
0 diff
(100 %id)
BQ003111 Chondrosarcoma, Left Pelvis .b 2190 to 2788 617 to 20   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 598/598
(100 %)
1 diff
(99.9 %id)
BQ219032 epithelioid carcinoma, Pancreas .b 2191 to 2790 1 to 600   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 600/600
(100 %)
0 diff
(100 %id)
AV735173 pheochromocytoma .b 2197 to 2638 1 to 443       443/469
(94 %)
17 diff
(96.4 %id)
BU598392 mixed (pool of 40 RNAs) .b 2199 to 2547 1 to 349       349/926
(37 %)
4 diff
(99.6 %id)
AL563242 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .b 2210 to 2766 559 to 1       559/559
(100 %)
28 diff
(95.0 %id)
AU150577   .b 2215 to 2798 578 to 1       582/578
(100 %)
14 diff
(97.6 %id)
BE276346 melanotic melanoma, skin .b 2220 to 2792 1 to 569       569/571
(99 %)
6 diff
(99.0 %id)
AA285045 germinal center B cell .b 2224 to 2605 1 to 382     Submitted on the opposite strand 382/382
(100 %)
0 diff
(100 %id)
BP346141 synovial membrane .b 2224 to 2790 1 to 569   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 569/569
(100 %)
5 diff
(99.2 %id)
CK902477 Pancreas, Purified pancreatic islet .b 2229 to 2782 565 to 12   AAA Submitted on the opposite strand 554/554
(100 %)
0 diff
(100 %id)
BQ771589 Chondrosarcoma Grade II, Left Pelvis .b 2238 to 2792 571 to 17       555/571
(97 %)
0 diff
(100 %id)
BM680664 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 2240 to 2782 561 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 543/543
(100 %)
1 diff
(99.9 %id)
BG472129 eye, retinoblastoma .b 2247 to 2387 1 to 142       142/142
(100 %)
5 diff
(96.5 %id)
BG472797 eye, retinoblastoma .b 2247 to 2387 1 to 141       141/141
(100 %)
1 diff
(99.3 %id)
BU727426 eye, optic nerve .b 2248 to 2789 560 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 542/553
(98 %)
1 diff
(99.9 %id)
CK429543 eye, lacrimal gland .b 2251 to 2792 1 to 542       542/544
(99 %)
1 diff
(99.9 %id)
BU736285 eye, fetal eyes .b 2270 to 2782 531 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 513/513
(100 %)
0 diff
(100 %id)
AW082821 colon, moderately differentiated adenocarcinoma .b 2275 to 2485 211 to 1       211/211
(100 %)
0 diff
(100 %id)
AA193297 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 2277 to 2789 1 to 520       520/523
(99 %)
11 diff
(97.9 %id)
AU156853 placenta .b 2280 to 2788 510 to 2       509/528
(96 %)
7 diff
(98.7 %id)
BQ188738 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 2296 to 2782 1 to 488   fully sequenced, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 488/488
(100 %)
2 diff
(99.6 %id)
TI_151733083   .b 2296 to 2782 546 to 62   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 485/1046
(46 %)
3 diff
(99.8 %id)
DB517447 testis .b 2305 to 2788 1 to 484     Submitted on the opposite strand 484/485
(99 %)
1 diff
(99.8 %id)
AA746017 Kidney .b 2314 to 2782 469 to 1       469/469
(100 %)
0 diff
(100 %id)
AI143267 heart .b 2317 to 2792 477 to 2       476/477
(99 %)
0 diff
(100 %id)
AW182304 pooled .b 2318 to 2792 477 to 3       475/477
(99 %)
0 diff
(100 %id)
AI754213 bone marrow stroma .b 2329 to 2782 472 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 454/454
(100 %)
0 diff
(100 %id)
AI889255 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 2332 to 2485 154 to 1       154/154
(100 %)
0 diff
(100 %id)
DB564772 hypothalamus .b 2333 to 2788 1 to 456     Submitted on the opposite strand 456/458
(99 %)
2 diff
(99.6 %id)
TI_149283319   .b 2333 to 2782 596 to 147   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 450/688
(65 %)
7 diff
(99.0 %id)
BU680174 lung, Primary Lung Epithelial Cells .b 2333 to 2782 468 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 450/456
(98 %)
7 diff
(98.5 %id)
AW129625 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 2334 to 2792 461 to 3       459/461
(99 %)
0 diff
(100 %id)
AI275034 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 2340 to 2788 452 to 3       450/453
(99 %)
1 diff
(99.8 %id)
AI984675 colon, colonic mucosa from 3 patients with Crohn'sdisease .b 2342 to 2790 466 to 18   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 449/449
(100 %)
4 diff
(99.2 %id)
AI084582 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 2346 to 2788 444 to 2       443/444
(99 %)
0 diff
(100 %id)
CA435656 lung, Metastatic Chondrosarcoma .b 2346 to 2782 455 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 437/437
(100 %)
0 diff
(100 %id)
N30668 placenta .b 2356 to 2788 447 to 3       445/451
(98 %)
0 diff
(100 %id)
BF475865 Prostate .b 2360 to 2791 432 to 1       432/432
(100 %)
0 diff
(100 %id)
AI081581 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 2362 to 2790 430 to 1       430/430
(100 %)
2 diff
(99.6 %id)
DB533932 hippocampus .b 2368 to 2781 1 to 414     Submitted on the opposite strand 414/415
(99 %)
7 diff
(98.4 %id)
TI_159716934   .b 2370 to 2792 447 to 25       423/1028
(41 %)
0 diff
(100 %id)
T34039 blood, white blood cells .b 2371 to 2651 1 to 281       281/281
(100 %)
0 diff
(100 %id)
AW954209   .b 2372 to 2788 1 to 417   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 417/417
(100 %)
0 diff
(100 %id)
BX099931 whole brain .b 2378 to 2789 426 to 15   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 412/412
(100 %)
0 diff
(100 %id)
BE774667 uterus .b 2383 to 2536 1 to 158       158/159
(99 %)
9 diff
(94.4 %id)
AI424020 brain, glioblastoma (pooled) .b 2383 to 2788 408 to 3       406/408
(99 %)
0 diff
(100 %id)
AI033555 liver and spleen .b 2385 to 2783 399 to 1       399/399
(100 %)
4 diff
(99.0 %id)
AV729690 hypothalamus .b 2396 to 2790 1 to 395       395/422
(93 %)
2 diff
(99.6 %id)
AA524496 colon .b 2405 to 2792 391 to 4       388/391
(99 %)
0 diff
(100 %id)
TI_149308284   .b 2408 to 2792 472 to 87       386/476
(81 %)
0 diff
(100 %id)
BU687137 lung, Primary Lung Epithelial Cells .b 2409 to 2792 401 to 17       385/401
(96 %)
0 diff
(100 %id)
AI810859 Prostate .b 2413 to 2790 378 to 1       378/378
(100 %)
1 diff
(99.8 %id)
AI420987 Prostate .b 2414 to 2790 377 to 1       377/377
(100 %)
0 diff
(100 %id)
AI041867 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 2424 to 2788 367 to 3       365/367
(99 %)
0 diff
(100 %id)
AI479676 anaplastic oligodendroglioma, brain .b 2426 to 2803 380 to 3   tiling clone,   378/380
(99 %)
0 diff
(100 %id)
AI498247 anaplastic oligodendroglioma, brain .b 2426 to 2799 374 to 1       374/374
(100 %)
0 diff
(100 %id)
AI274857 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 2434 to 2790 357 to 1       357/357
(100 %)
0 diff
(100 %id)
R40774 whole brain .b 2440 to 2790 372 to 11   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 362/362
(100 %)
12 diff
(96.7 %id)
AI245586 Kidney .b 2441 to 2783 343 to 1       343/343
(100 %)
0 diff
(100 %id)
AA470477 colon .b 2445 to 2803 363 to 5       359/363
(98 %)
0 diff
(100 %id)
BF675317 Prostate .b 2445 to 2776 1 to 333       333/333
(100 %)
1 diff
(99.7 %id)
DB513082 testis .b 2457 to 2788 1 to 333     Submitted on the opposite strand 333/335
(99 %)
16 diff
(95.3 %id)
AI004976 pooled .b 2460 to 2792 334 to 2       333/334
(99 %)
0 diff
(100 %id)
AA862812 pooled germ cell tumors .b 2461 to 2788 329 to 2       328/329
(99 %)
0 diff
(100 %id)
EC515271 Prostate .b 2466 to 2551 12 to 97       86/97
(88 %)
6 diff
(93.9 %id)
AW340620 pooled .b 2479 to 2788 310 to 1       310/310
(100 %)
0 diff
(100 %id)
AA282822 germinal center B cell .b 2485 to 2792 308 to 1     Submitted on the opposite strand 308/308
(100 %)
0 diff
(100 %id)
AA147218 Pancreas .b 2495 to 2790 309 to 14   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 296/299
(98 %)
2 diff
(99.4 %id)
AI985443 Kidney .b 2496 to 2789 296 to 3       294/296
(99 %)
0 diff
(100 %id)
AA070812   .b 2500 to 2765 265 to 1       265/265
(100 %)
1 diff
(99.7 %id)
AA669010 lung .b 2500 to 2788 290 to 2       289/290
(99 %)
0 diff
(100 %id)
AA676390   .b 2500 to 2790 311 to 21   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 291/291
(100 %)
10 diff
(96.6 %id)
AA827925 germinal center B cell .b 2500 to 2790 311 to 21   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 291/291
(100 %)
0 diff
(100 %id)
AI524393 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 2500 to 2792 293 to 1       293/293
(100 %)
2 diff
(99.4 %id)
AI829295 adenocarcinoma, Pancreas .b 2500 to 2790 292 to 1       292/292
(100 %)
8 diff
(97.3 %id)
F17833 pectoral muscle (after mastectomy) .b 2501 to 2788 1 to 285       285/288
(98 %)
6 diff
(98.0 %id)
D19675   .b 2503 to 2792 1 to 290     Submitted on the opposite strand 290/291
(99 %)
3 diff
(99.0 %id)
AA742955 germinal center B cell .b 2507 to 2633 126 to 1       126/126
(100 %)
1 diff
(99.3 %id)
AI184426 heart .b 2512 to 2790 281 to 1       281/281
(100 %)
2 diff
(99.3 %id)
T32719 heart .b 2517 to 2782 266 to 1       266/266
(100 %)
0 diff
(100 %id)
BF155082 breast .b 2522 to 2697 5 to 177       173/189
(91 %)
3 diff
(98.5 %id)
AA552130 colon, tumor .b 2524 to 2790 269 to 1       269/269
(100 %)
5 diff
(98.2 %id)
T35299 prostate gland .b 2529 to 2792 268 to 5       264/268
(98 %)
0 diff
(100 %id)
AW732132 lung, small cell carcinoma .b 2530 to 2792 264 to 2   available from MGC,   263/264
(99 %)
0 diff
(100 %id)
AW294232   .b 2539 to 2798 277 to 18   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 260/260
(100 %)
0 diff
(100 %id)
FN046774 breast carcinoma .b 2541 to 2629 89 to 1     Submitted on the opposite strand 89/91
(97 %)
0 diff
(100 %id)
AA662529 normal prostate, Prostate .b 2548 to 2790 243 to 1       243/243
(100 %)
0 diff
(100 %id)
AI611263 Prostate .b 2551 to 2790 240 to 1       240/240
(100 %)
0 diff
(100 %id)
AI918275 anaplastic oligodendroglioma, brain .b 2557 to 2799 246 to 1       246/246
(100 %)
7 diff
(97.2 %id)
CK300205 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 2563 to 2782 238 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 220/220
(100 %)
0 diff
(100 %id)
BQ229298 embryonal carcinoma, cell line, testis .b 2575 to 2782 1 to 208   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 208/208
(100 %)
0 diff
(100 %id)
AI693004 pooled .b 2578 to 2782 217 to 13   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 205/205
(100 %)
0 diff
(100 %id)
T15443   .b 2595 to 2790 196 to 1       196/203
(96 %)
0 diff
(100 %id)
N59872 multiple sclerosis lesions .b 2613 to 2782 187 to 18   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 170/170
(100 %)
0 diff
(100 %id)
AW196058 adenocarcinoma, Pancreas .b 2613 to 2784 172 to 1       172/172
(100 %)
0 diff
(100 %id)
AI824556 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 2619 to 2789 171 to 1       171/171
(100 %)
0 diff
(100 %id)
AI453266 adenocarcinoma, Pancreas .b 2651 to 2790 140 to 1       140/140
(100 %)
0 diff
(100 %id)
DA907861   .c 1 to 749 2 to 750   tiling clone, capped   749/749
(100 %)
3 diff
(99.6 %id)
DB331355   .c 1776 to 2285 515 to 10   tiling clone,   506/543
(93 %)
7 diff
(98.8 %id)
CX761576 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .d 1 to 752 1 to 747   tiling clone, Submitted on the opposite strand 747/842
(88 %)
5 diff
(99.5 %id)
N90962 liver and spleen .d 581 to 1037 1 to 459   tiling clone,   459/460
(99 %)
10 diff
(97.9 %id)
N69470 liver and spleen .d 1057 to 1485 430 to 1   tiling clone,   430/433
(99 %)
2 diff
(99.6 %id)
BQ440275 melanotic melanoma, skin .e 1 to 813 1 to 822   tiling clone,   822/826
(99 %)
12 diff
(98.6 %id)
AA131472   .e 175 to 714 7 to 546   tiling clone,   540/546
(98 %)
6 diff
(99.0 %id)
AA354027   .e 706 to 1064 1 to 359   tiling clone,   359/359
(100 %)
1 diff
(99.8 %id)
AI174660   .e 737 to 1158 423 to 1       423/423
(100 %)
2 diff
(99.6 %id)
BP199747 brain .e 756 to 1338 1 to 583   tiling clone,   583/583
(100 %)
0 diff
(100 %id)
TI_57181736   .f 1 to 881 28 to 913   tiling clone,   884/985
(89 %)
27 diff
(97.3 %id)
BI768918 pooled lung and spleen .f 6 to 881 1 to 882   tiling clone,   880/954
(92 %)
21 diff
(97.8 %id)
DA311624 hippocampus .f 877 to 1446 2 to 571   tiling clone, capped   570/570
(100 %)
0 diff
(100 %id)
DB215508 trachea .f 877 to 1330 2 to 455   capped   454/454
(100 %)
4 diff
(99.2 %id)
BE242879 leukopheresis .f 1372 to 1793 1 to 421   tiling clone,   421/421
(100 %)
5 diff
(98.9 %id)
DA858979 placenta .f 1452 to 1998 2 to 547   tiling clone, capped   546/546
(100 %)
3 diff
(99.5 %id)
BP419365 small intestine .f 1522 to 1940 1 to 419     Submitted on the opposite strand 419/419
(100 %)
3 diff
(99.3 %id)
BU146402 brain, neuroblastoma, cell line .g 1 to 808 56 to 867   tiling clone,   815/970
(84 %)
25 diff
(97.5 %id)
BX484086   .g 805 to 1336 1 to 532   tiling clone,   532/532
(100 %)
0 diff
(100 %id)
BQ927028 large cell carcinoma, lung .h 1 to 633 1 to 634   tiling clone,   634/859
(73 %)
11 diff
(98.8 %id)
DA687377   .h 24 to 560 2 to 538   capped   537/537
(100 %)
1 diff
(99.9 %id)
AI741118 pooled .h 543 to 1038 514 to 19   tiling clone, AAA   496/496
(100 %)
0 diff
(100 %id)
AI001157   .h 545 to 1042 498 to 1   tiling clone,   498/498
(100 %)
8 diff
(98.4 %id)
AI338503   .h 606 to 1042 440 to 4       437/440
(99 %)
0 diff
(100 %id)
AA912075 pharynx, squamous cell carcinoma .h 735 to 1038 304 to 1       304/304
(100 %)
5 diff
(98.4 %id)
TI_1948148013   .i 1 to 730 726 to 125 L5P H6P L7F M8N L9V ... tiling clone,   596/1380
(43 %)
19 diff
(98.7 %id)
CK430909 eye, lacrimal gland .i 30 to 601 1 to 572   tiling clone,   572/572
(100 %)
0 diff
(100 %id)
BX088658 colon, moderately-differentiated adenocarcinoma .j-u 1 to 483 485 to 1   tiling clone, Submitted on the opposite strand 485/490
(98 %)
3 diff
(99.4 %id)
AI355771 colon, moderately-differentiated adenocarcinoma .j-u 162 to 471 313 to 4       310/313
(99 %)
0 diff
(100 %id)
BY795934 eye .j-u 171 to 794 1 to 624   tiling clone,   624/624
(100 %)
1 diff
(99.9 %id)
BF823118 kidney_tumor .j-u 353 to 763 407 to 2     Submitted on the opposite strand 406/407
(99 %)
0 diff
(100 %id)
FN169231 breast carcinoma .j-u 495 to 584 89 to 1     Submitted on the opposite strand 89/89
(100 %)
1 diff
(98.9 %id)
AI917191 pooled germ cell tumors .j-u 562 to 1053 492 to 1   tiling clone,   492/492
(100 %)
0 diff
(100 %id)
AW002398 pooled germ cell tumors .j-u 579 to 1053 477 to 3       475/477
(99 %)
0 diff
(100 %id)
AI963903 pooled germ cell tumors .j-u 585 to 1053 469 to 1       469/469
(100 %)
0 diff
(100 %id)
AW293664   .j-u 710 to 1053 360 to 18   AAA   343/343
(100 %)
1 diff
(99.8 %id)
AW292521   .j-u 774 to 1053 297 to 18   AAA   280/280
(100 %)
0 diff
(100 %id)
DB240748 trachea .j-u 1003 to 1592 2 to 591   tiling clone, capped   590/590
(100 %)
3 diff
(99.5 %id)
DB350590 trachea .j-u 2249 to 2801 553 to 1   tiling clone,   553/553
(100 %)
1 diff
(99.9 %id)
DA202400 brain .k 1 to 563 2 to 564 exact tiling clone, capped   563/563
(100 %)
0 diff
(100 %id)
BG700070 brain, hippocampus .l 1 to 634 6 to 639 A2V D43T C44A E45S F46S ... tiling clone,   634/639
(99 %)
7 diff
(99.0 %id)
BI752917 brain .l 13 to 838 1 to 828   tiling clone,   828/828
(100 %)
12 diff
(98.6 %id)
TI_57219741   .l 13 to 838 72 to 899       828/899
(92 %)
18 diff
(98.0 %id)
BX114206 brain, glioblastoma (pooled) .l 445 to 916 1 to 472   tiling clone,   472/472
(100 %)
0 diff
(100 %id)
AI362013 brain, glioblastoma (pooled) .l 816 to 1353 538 to 1       538/538
(100 %)
7 diff
(98.7 %id)
AA883399 pooled .l 822 to 1212 391 to 1       391/391
(100 %)
3 diff
(99.3 %id)
BF438722 brain, glioblastoma (pooled) .l 846 to 1352 507 to 1   tiling clone,   507/507
(100 %)
1 diff
(99.9 %id)
BE855514 brain, glioblastoma (pooled) .l 877 to 1352 476 to 1       476/476
(100 %)
1 diff
(99.8 %id)
CD653471 Embryonic Stem cells .l 995 to 1796 6 to 801   tiling clone,   796/801
(99 %)
6 diff
(99.3 %id)
DB553716 hypothalamus .l 1029 to 1463 1 to 437   tiling clone, Submitted on the opposite strand 437/437
(100 %)
3 diff
(99.4 %id)
TI_149272695   .m 1 to 788 859 to 84 exact tiling clone, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 776/954
(81 %)
18 diff
(98.2 %id)
BU675258 lung, Primary Lung Epithelial Cells .m 147 to 788 659 to 19 exact tiling clone, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 641/641
(100 %)
2 diff
(99.7 %id)
DB283553 uterus .n 1 to 541 2 to 542   tiling clone, capped   541/541
(100 %)
0 diff
(100 %id)
DA322015 hippocampus .n 108 to 650 2 to 545   capped   544/549
(99 %)
3 diff
(99.5 %id)
DA241529 brain .n 167 to 752 2 to 588   capped   587/590
(99 %)
6 diff
(99.0 %id)
DA192361 amygdala .n 189 to 795 2 to 608   capped   607/607
(100 %)
0 diff
(100 %id)
BE244387 leukopheresis .n 256 to 679 1 to 424       424/425
(99 %)
1 diff
(99.8 %id)
BE244392 leukopheresis .n 256 to 378 1 to 123       123/123
(100 %)
1 diff
(99.2 %id)
CD558128 testis .n 270 to 1091 29 to 853       825/855
(96 %)
10 diff
(98.9 %id)
DA108012 cerebellum .n 313 to 871 2 to 560   tiling clone, capped   559/559
(100 %)
0 diff
(100 %id)
DB128828 thymus .n 433 to 989 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
DA272679 caudate nucleus .n 553 to 1047 2 to 497   capped   496/496
(100 %)
3 diff
(99.4 %id)
DA854739 placenta .n 676 to 1261 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
DA246332 brain .n 683 to 1278 2 to 597   tiling clone, capped   596/596
(100 %)
0 diff
(100 %id)
DB137408 thymus .n 701 to 1248 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DA089159 cerebellum .n 837 to 1412 2 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
DA089199 cerebellum .n 837 to 1310 2 to 474   capped   473/473
(100 %)
1 diff
(99.8 %id)
DA299338 hippocampus .n 931 to 1485 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
CK003610 brain/CNS, Human Brain - Cerebellar Cortex .n 1079 to 1694 1 to 612   tiling clone,   612/665
(92 %)
6 diff
(99.1 %id)
AL711572 human skeletal muscle .n 1289 to 1887 12 to 610       599/610
(98 %)
6 diff
(99.1 %id)
BX645191   .n 1348 to 1899 1 to 552       552/552
(100 %)
0 diff
(100 %id)
DA864892 placenta .n 1348 to 1899 2 to 553   capped   552/552
(100 %)
1 diff
(99.9 %id)
DA242134 brain .n 1395 to 1978 2 to 585   tiling clone, capped   584/584
(100 %)
0 diff
(100 %id)
H86702 eye, retina .n 1413 to 1803 1 to 395       395/397
(99 %)
6 diff
(98.5 %id)
CN283721 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .n 1460 to 1920 1 to 461       461/461
(100 %)
1 diff
(99.8 %id)
BY796020 eye .n 1702 to 2303 1 to 602       602/602
(100 %)
1 diff
(99.9 %id)
R85137 brain .n 1805 to 2229 1 to 429       429/434
(98 %)
5 diff
(98.9 %id)
CK004597 brain/CNS, Human Brain - Frontal Cortex .n 1893 to 2518 1 to 625       625/625
(100 %)
4 diff
(99.4 %id)
BP425020 small intestine .n 1896 to 2447 1 to 552   tiling clone, Submitted on the opposite strand 552/552
(100 %)
0 diff
(100 %id)
AA001270 liver and spleen .n 1901 to 2390 1 to 499       499/544
(91 %)
14 diff
(97.5 %id)
AV749809 Pituitary .n 2047 to 2353 1 to 305       305/357
(85 %)
8 diff
(97.8 %id)
W26537 eye, retina .n 2048 to 2550 547 to 37       511/568
(89 %)
0 diff
(100 %id)
DT217593 brain .n 2133 to 2738 1 to 607       607/607
(100 %)
3 diff
(99.6 %id)
BF928178 nervous_tumor .n 2217 to 2523 7 to 312       306/314
(97 %)
10 diff
(96.9 %id)
DA107628 cerebellum .n 2238 to 2772 2 to 536   fully sequenced, capped   535/535
(100 %)
0 diff
(100 %id)
BF927326 nervous_tumor .n 2251 to 2573 27 to 348       322/348
(92 %)
6 diff
(98.3 %id)
AA334311   .n 2285 to 2536 1 to 252       252/252
(100 %)
0 diff
(100 %id)
AW965413   .n 2286 to 2701 1 to 416       416/507
(82 %)
29 diff
(94.3 %id)
CK005454 brain/CNS, Human Brain - Frontal Cortex .n 2422 to 3108 1 to 682 exact tiling clone,   682/684
(99 %)
12 diff
(98.3 %id)
AA770564 carcinoid, lung .n 2457 to 2655 1 to 199     Submitted on the opposite strand 199/199
(100 %)
0 diff
(100 %id)
DB307064 caudate nucleus .n 2589 to 3128 540 to 1 exact     540/540
(100 %)
0 diff
(100 %id)
AA001867 liver and spleen .n 2711 to 3122 417 to 1       417/421
(99 %)
5 diff
(98.9 %id)
DB299607 cerebellum .n 2742 to 3130 389 to 1   tiling clone, fully sequenced,   389/389
(100 %)
0 diff
(100 %id)
R85087 brain .n 2896 to 3110 221 to 6       216/221
(97 %)
0 diff
(100 %id)
BM695520 eye, optic nerve .o-u 1 to 751 1 to 751   tiling clone, Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 751/751
(100 %)
3 diff
(99.7 %id)
BF939683 brain, glioblastoma (pooled) .o-u 369 to 885 517 to 1 exact tiling clone,   517/517
(100 %)
0 diff
(100 %id)
BU728934 eye, optic nerve .o-u 884 to 1549 684 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 666/666
(100 %)
1 diff
(99.9 %id)
DB126771 thymus .o-u 996 to 1625 2 to 632   tiling clone, capped   631/631
(100 %)
1 diff
(99.9 %id)
AV764118 bone marrow .o-u 1089 to 1495 1 to 398       398/399
(99 %)
5 diff
(98.8 %id)
DA261284 caudate nucleus .o-u 1105 to 1651 2 to 549   tiling clone, capped   548/548
(100 %)
2 diff
(99.7 %id)
AI431248 aorta .o-u 1176 to 1567 452 to 60       393/452
(86 %)
0 diff
(100 %id)
BG680006 skin, squamous cell carcinoma .o-u 1208 to 1901 1 to 708       708/1120
(63 %)
28 diff
(97.5 %id)
BE834012 ovary .o-u 1229 to 1573 1 to 343       343/347
(98 %)
6 diff
(98.3 %id)
CN275964 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .o-u 1580 to 1914 1 to 335       335/335
(100 %)
5 diff
(98.6 %id)
BF197585 Kidney .o-u 1584 to 1998 415 to 1   tiling clone,   415/415
(100 %)
0 diff
(100 %id)
Z44302 brain, total brain .o-u 1590 to 1917 1 to 328       328/328
(100 %)
0 diff
(100 %id)
AU311497 neuroblastoma .o-u 1610 to 1893 1 to 280       280/283
(98 %)
7 diff
(97.6 %id)
BM729014 eye, fetal eye .o-u 1850 to 2530 1 to 681     Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 681/681
(100 %)
3 diff
(99.6 %id)
AU311819 neuroblastoma .o-u 1964 to 2540 1 to 577   tiling clone,   577/577
(100 %)
0 diff
(100 %id)
AA703584 liver and spleen .o-u 1970 to 2382 1 to 413     Submitted on the opposite strand 413/413
(100 %)
0 diff
(100 %id)
W25046 lung .o-u 1997 to 2396 1 to 407       407/407
(100 %)
20 diff
(95.1 %id)
AA114990 uterus .o-u 2033 to 2671 1 to 644       644/646
(99 %)
16 diff
(97.6 %id)
W03763 liver and spleen .o-u 2036 to 2481 1 to 448       448/448
(100 %)
2 diff
(99.6 %id)
BM756097 Ascites, stomach .o-u 2125 to 2796 1 to 672   tiling clone,   672/679
(98 %)
1 diff
(99.9 %id)
R21004 whole brain .o-u 2140 to 2516 1 to 383       383/386
(99 %)
13 diff
(96.7 %id)
AI279206 carcinoid, lung .o-u 2223 to 2729 1 to 507     Submitted on the opposite strand 507/507
(100 %)
1 diff
(99.9 %id)
AA370895 Prostate .o-u 2225 to 2448 1 to 224       224/224
(100 %)
1 diff
(99.6 %id)
BE925209 amnion_normal .o-u 2250 to 2454 10 to 215       206/216
(95 %)
4 diff
(98.2 %id)
BG676693 skin, squamous cell carcinoma .o-u 2374 to 2934 1 to 561       561/561
(100 %)
1 diff
(99.9 %id)
CN289489 embryonic stem cells, DMSO-treated H9 cellline .o-u 2405 to 2757 1 to 353       353/353
(100 %)
9 diff
(97.5 %id)
BF852169 lung_normal .o-u 2547 to 3121 1 to 572       572/572
(100 %)
6 diff
(99.0 %id)
TI_149303440   .o-u 2548 to 3483 999 to 80   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 920/1001
(91 %)
33 diff
(96.8 %id)
BF852083 lung_normal .o-u 2555 to 3092 17 to 551       535/552
(96 %)
41 diff
(92.6 %id)
TI_154047784   .o-u 2649 to 3491 933 to 94   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 840/1008
(83 %)
9 diff
(99.2 %id)
TI_149299700   .o-u 2691 to 3478 875 to 93   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 783/943
(83 %)
0 diff
(100 %id)
BE242954 leukopheresis .o-u 2713 to 3080 368 to 1       368/368
(100 %)
0 diff
(100 %id)
AA055379 heart .o-u 2743 to 3104 1 to 363   fully sequenced,   363/363
(100 %)
1 diff
(99.8 %id)
BM681957 eye, fetal eye .o-u 2749 to 3483 753 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 735/739
(99 %)
2 diff
(99.8 %id)
BQ008048 Chondrosarcoma, Left Pelvis .o-u 2751 to 3475 743 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 725/725
(100 %)
0 diff
(100 %id)
CA412934 Chondrosarcoma Grade II, Left Pelvis .o-u 2754 to 3491 756 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 738/738
(100 %)
1 diff
(99.9 %id)
BI040139 nervous_tumor .o-u 2775 to 3086 1 to 312       312/312
(100 %)
1 diff
(99.7 %id)
CV425908 nervous_tumor .o-u 2775 to 3086 312 to 1     Submitted on the opposite strand 312/312
(100 %)
4 diff
(98.8 %id)
CV425917 nervous_tumor .o-u 2775 to 3086 313 to 1     Submitted on the opposite strand 313/313
(100 %)
10 diff
(96.9 %id)
BQ778081 Pancreas, Purified pancreatic islet .o-u 2811 to 3108 1 to 299   fully sequenced,   299/299
(100 %)
3 diff
(99.0 %id)
CA950961 Pancreas, Purified pancreatic islet .o-u 2814 to 3129 46 to 361       316/361
(87 %)
6 diff
(98.4 %id)
AA115512 uterus .o-u 2815 to 3447 657 to 37       621/660
(94 %)
0 diff
(100 %id)
BM981459 lung, Primary Lung Cystic Fibrosis EpithelialCells .o-u 2855 to 3483 647 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 629/629
(100 %)
0 diff
(100 %id)
BQ005490 Chondrosarcoma, Left Pelvis .o-u 2856 to 3481 645 to 20   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 626/626
(100 %)
0 diff
(100 %id)
AI889517 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .o-u 2893 to 3178 286 to 1       286/286
(100 %)
0 diff
(100 %id)
AI910890 pooled .o-u 2927 to 3481 557 to 3       555/557
(99 %)
0 diff
(100 %id)
BF439353 pooled .o-u 2927 to 3482 556 to 1       556/556
(100 %)
0 diff
(100 %id)
AI436774 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .o-u 2932 to 3481 552 to 3       550/552
(99 %)
0 diff
(100 %id)
BM975995 lung, Primary Lung Cystic Fibrosis EpithelialCells .o-u 2935 to 3478 566 to 23   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 544/547
(99 %)
0 diff
(100 %id)
DB306691 caudate nucleus .o-u 2958 to 3482 527 to 1       527/527
(100 %)
2 diff
(99.7 %id)
AI431663 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .o-u 3000 to 3485 487 to 2       486/487
(99 %)
0 diff
(100 %id)
AI185201 lung .o-u 3006 to 3475 476 to 8       469/476
(98 %)
0 diff
(100 %id)
AI224859 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .o-u 3006 to 3481 479 to 4       476/479
(99 %)
0 diff
(100 %id)
AW592594 pooled .o-u 3018 to 3485 470 to 3       468/470
(99 %)
0 diff
(100 %id)
N95606 lung .o-u 3023 to 3483 460 to 1       460/460
(100 %)
1 diff
(99.8 %id)
AI027611   .o-u 3033 to 3485 457 to 5       453/457
(99 %)
0 diff
(100 %id)
AI635612 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .o-u 3037 to 3178 142 to 1       142/142
(100 %)
0 diff
(100 %id)
AW474839 lymph node, lymphoma, follicular mixed small and largecell .o-u 3038 to 3178 141 to 1       141/141
(100 %)
1 diff
(99.3 %id)
AI151227 placenta .o-u 3056 to 3485 432 to 3       430/432
(99 %)
0 diff
(100 %id)
AA055891 heart .o-u 3074 to 3483 417 to 1   fully sequenced,   417/417
(100 %)
4 diff
(99.1 %id)
BQ777774 Pancreas, Purified pancreatic islet .o-u 3078 to 3481 404 to 1   fully sequenced,   404/404
(100 %)
1 diff
(99.8 %id)
N79245 liver and spleen .o-u 3092 to 3485 397 to 1       397/397
(100 %)
3 diff
(99.3 %id)
R46125 whole brain .o-u 3173 to 3482 329 to 15       315/331
(95 %)
0 diff
(100 %id)
Z40261 brain, total brain .o-u 3213 to 3475 263 to 1       263/263
(100 %)
0 diff
(100 %id)
CA950715 Pancreas, Purified pancreatic islet .o-u 3218 to 3481 264 to 1       264/264
(100 %)
0 diff
(100 %id)
AK092931 Spleen .p 1 to 2332 2 to 2333 H25D tiling clone, available from FLJ,   2333/2333
(100 %)
9 diff
(99.7 %id)
DA937339 Spleen .p 1 to 589 2 to 590   capped   589/589
(100 %)
1 diff
(99.9 %id)
H79830 liver and spleen .p 351 to 674 340 to 1 V2* tiling clone, fully sequenced,   340/340
(100 %)
7 diff
(98.0 %id)
DB332926 Spleen .p 1795 to 2332 538 to 1       538/538
(100 %)
8 diff
(98.6 %id)
DW448035 Liver .p 1899 to 2092 17 to 210       194/210
(92 %)
6 diff
(97.2 %id)
CN285245 embryonic stem cells, cell lines H1, H7, andH9 .q-u 1 to 249 1 to 249   tiling clone,   249/249
(100 %)
0 diff
(100 %id)
BG957071 colon .q-u 245 to 795 169 to 714 S2F V3P F4S Q5C A6E ... tiling clone,   546/714
(76 %)
6 diff
(99.2 %id)
BG960509 colon .q-u 396 to 956 564 to 2       563/564
(99 %)
0 diff
(100 %id)
AA743623 germinal center B cell .q-u 468 to 899 1 to 432       432/432
(100 %)
0 diff
(100 %id)
BG956986 colon .q-u 525 to 1114 590 to 1   tiling clone,   590/590
(100 %)
1 diff
(99.9 %id)
CB962301 Blood vessels - aorta, basilar and artery .q-u 658 to 1223 1 to 566   tiling clone,   566/751
(75 %)
9 diff
(98.9 %id)
BG956991 colon .q-u 816 to 1101 286 to 1       286/286
(100 %)
0 diff
(100 %id)
M78528   .q-u 1054 to 1416 1 to 363   tiling clone,   363/363
(100 %)
1 diff
(99.8 %id)
DB108688 thymus .r-u 1 to 577 2 to 579 Q8R N18G R26G M32V C40R ... tiling clone, capped   578/578
(100 %)
18 diff
(96.9 %id)
DA518751 brain .s 1 to 555 2 to 556 exact tiling clone, capped   555/555
(100 %)
0 diff
(100 %id)
DA280406 corpus callosum .s 26 to 574 2 to 550 exact tiling clone, capped   549/549
(100 %)
0 diff
(100 %id)
DB484700 hypothalamus .s 35 to 483 1 to 451 Q12H R33P S34Q L35P Y36S ...     451/452
(99 %)
15 diff
(96.7 %id)
AA320867 adipose tissue, white .t-u 1 to 304 9 to 313 L6X D11X N29X F62X Q93R tiling clone,   313/314
(99 %)
4 diff
(98.8 %id)
BE708613 head_neck .u 1 to 213 1 to 213 exact tiling clone,   213/213
(100 %)
0 diff
(100 %id)
AV714904   Gene INTS10, variant not shown       AAA This clone was ignored    
AV716485   Gene INTS10, variant not shown         This clone was ignored    
DB468226 hippocampus Gene INTS10, variant not shown              
DB471060 hippocampus Gene INTS10, variant not shown              
DB465139 hippocampus Gene INTS10, variant not shown              
EB386003 eye, optic nerve Gene INTS10, variant not shown       AAA Submitted on the opposite strand, submitted on the opposite strand    
DB125069 thymus Gene INTS10, variant not shown       capped Suspected internal deletion, this clone was ignored    
T32720 heart Gene INTS10, variant not shown         This clone was ignored    
DB300189 cerebellum Gene INTS10, variant not shown         This clone was ignored    
DA116014 cerebellum Gene INTS10, variant not shown       capped This clone was ignored    
BQ028905 Bone, Subchondral Bone Gene INTS10, variant not shown       AAA Suspected internal deletion, this clone was ignored    
CK004917 brain/CNS, Human Brain - Frontal Cortex Gene INTS10, variant not shown         Suspected internal deletion, this clone was ignored    
DB148272 thymus Gene INTS10, variant not shown       capped This clone was ignored    
DB345911 thymus Gene INTS10, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j-u, .k, .l, .m, .n, .o-u, .p, .q-u, .r-u, .s, .t-u, .u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI